Visit the ABcann Global Investor Dashboard and stay up to date with data-driven, fact based due diligence for active traders and investors.
ABcann Global Announces Listing on the OTCQB Marketplace and the Frankfurt Stock Exchange
OTTAWA, July 12, 2017 (GLOBE NEWSWIRE) — ABcann Global Corporation (TSXV: ABCN) (OTC: ABCCF) (“ABcann” or the “Company”) is pleased to announce that its common shares have been approved for trading on the OTCQB Marketplace (the “OTCQB”) under the symbol “ABCCF” and on the Frankfurt Stock Exchange (the “FSE”) under the symbol “23Q”. The Company’s common shares will continue to trade on the TSX Venture Exchange under the symbol “ABCN”.
The Company expects to benefit from being listed on the OTCQB and the FSE by gaining greater visibility and convenience of trading the Company’s common shares to US and European investors, allowing a much larger potential shareholder base and enhanced liquidity.
About ABcann Global Corporation (TSX-V:ABCN):
ABcann was one of the first companies to obtain a production license under the Marijuana for Medical Purposes Regulations, which it received on March 21, 2014. It obtained a sales license on December 31, 2015. ABcann’s flagship facility, in Napanee, Ontario, contains proprietary plant-growing technology, including environmentally-controlled chambers capable of monitoring and regulating all variables in the growing process. This approach and the systems in place allow ABcann to produce organically grown and pesticide-free, high-yielding plants, which, in turn, can generate high-quality products that are consistent from batch to batch. ABcann is able to control environmental and nutrient demands, tailor-made for a particular strain of cannabis, without the variation that is typical when producing large quantities in less-controlled, larger rooms and greenhouse-type structures. ABcann’s modular approach to systems technology eliminates scale-up risk and allows ABcann to locate anywhere in the world and maintain consistency and quality of product.
ABcann is expanding capacity in its current facility to approximately 30,000 sq ft and concurrently undertaking expansion into a new 150,000 sq ft facility in Napanee. ABcann is pursuing opportunities in Germany, Australia and other jurisdictions as well as exploring the development of multiple delivery vehicles.
The most reliable, fact-based information on ABcann Global found only on its Investor Dashboard.
Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.